Cytek Biosciences raised $120M Series D venture round, led by Hillhouse Capital.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Private | — |
| Private Equity | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$120M
Top Valuation
-
Cytek Biosciences raised $120M in a Series D round.
The round was announced on 11/05/20.
The round was led by Hillhouse Capital, Andrew Levin.